Drug-Drug Interactions With DOACs: An Ongoing Concern
Medscape,
This transcript has been edited for clarity. Michael E. Field, MD, FHRS: Hi. I'm Michael Field.
This transcript has been edited for clarity. Michael E. Field, MD, FHRS: Hi. I'm Michael Field.
This transcript has been edited for clarity. Michael E. Field, MD, FHRS: Hi. I'm Michael Field.
Patients on oral anticoagulants who experience a bleeding event may be able to discontinue therapy if certain circumstances…
Patients on oral anticoagulants who experience a bleeding event may be able to discontinue therapy if certain circumstances…